642 Participants Needed

Baby2Home Mobile Application for Mental Health Wellness

Recruiting at 1 trial location
CG
JS
Overseen ByJoshua Santiago, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Women and Infants Hospital of Rhode Island
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests Baby2Home, a digital program to help new parents and their babies. It aims to improve health outcomes and reduce disparities for families affected by COVID-19. The program provides education, wellness tracking, mental health support, and regular check-ins.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the Baby2Home Mobile Application treatment for mental health wellness?

Research on similar digital health technologies for peripartum depression suggests that mobile applications can improve mental health outcomes by offering anonymity, flexibility, and promoting help-seeking. These apps are seen as beneficial for perinatal mental health, especially when they are customizable and user-friendly.12345

Is the Baby2Home Mobile Application generally safe for use in humans?

There is no specific safety data available for the Baby2Home Mobile Application, but mobile health apps in general are considered safe as they primarily provide information and support without direct medical intervention.26789

How does the Baby2Home Mobile Application treatment differ from other treatments for mental health wellness in new parents?

The Baby2Home Mobile Application is unique because it provides mental health support for new parents through a mobile app, making it convenient and accessible. Unlike traditional face-to-face therapy, this app offers anonymity and flexibility, which can help overcome barriers to seeking help and improve adherence to mental health interventions.510111213

Research Team

CC

Craig Craig, MD

Principal Investigator

Lurie Children's Hospital

Eligibility Criteria

This trial is for new parents with a healthy, full-term baby (≥37 weeks) born at specific hospitals. Participants must be over 18, speak English, have smartphone access and an email address. It's not for those whose infant passed away or needs NICU care, have severe mental illness, are in certain other studies, experienced IPV with the current partner or lack clinical clearance post-COVID-19 infection.

Inclusion Criteria

I have a working email address.
Delivery at Prentice Women's Hospital or Women and Infants Hospital of Rhode Island
Access to a smartphone
See 2 more

Exclusion Criteria

Concurrent enrollment in studies that may affect the outcome of the trial (or vice versa)
Babies who have passed away.
My infant needs to be admitted to the NICU.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Families receive the Baby2Home (B2H) digital health intervention via a smartphone app, which includes parental education, infant wellness resources, mental health screening, and support.

12 months
Baseline, 1M, 2M, 4M, 6M, and 12M

Follow-up

Participants are monitored for health service utilization and patient-reported outcomes over the first year postpartum.

12 months
Ongoing monitoring through app and surveys

Treatment Details

Interventions

  • Baby2Home Mobile Application
Trial Overview The Baby2Home Mobile Application is being tested to see if it can improve healthcare service use and parental outcomes during the first year after birth compared to usual care. The study also looks at whether it reduces health disparities based on race/ethnicity and income.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Baby2Home InterventionExperimental Treatment1 Intervention
Families randomized to the intervention arm will receive the B2H services. B2H is a novel digitized CC-based intervention delivered via a smartphone app available on iOS or Android phones, built by combining two successful programs: NICU2Home+ app and CC services. Using the UCD methodologies, AI-based communication within the app will include education for mothers and fathers on the standard of care regarding self-care and newborn care after hospital discharge as well as education, reminders and scheduling for recommended preventative healthcare services for themselves and their new infant.
Group II: Usual CareActive Control1 Intervention
As a pragmatic trial, usual care will be defined by contemporary clinical standards. For maternal care, this includes a comprehensive medical visit between 4-12 weeks postpartum. This visit includes utilization of a validated screen for postpartum depression and, if that screen is positive, a clinical assessment and initiation of treatment (e.g. pharmacotherapy or referral for psychotherapy). In addition, this visit includes a discussion of contraception as well as supportive education on breastfeeding. For paternal care, clinical standards are gleaned from the AAP, ACOG, and USPSTF reports outlining mental health screening, reproductive health, and vaccine uptake. For infant care, standard pediatric care from the AAP and Bright Futures periodicity timeline and guidelines will be used. In addition, assignment in this arm will be given surveys at baseline, 1M, 2M, 4M, 6M, and 12M.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Women and Infants Hospital of Rhode Island

Lead Sponsor

Trials
119
Recruited
59,200+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Findings from Research

The mood tracking and alert (MTA) mobile app significantly increased mental health care contacts for pregnant women with depressive symptoms, leading to better management of their health compared to those using a standard patient portal app.
Women using the MTA app were more likely to receive referrals to mental health specialists, highlighting its effectiveness in improving service delivery and patient engagement in a high-risk obstetric population.
A Mobile Application for Monitoring and Management of Depressed Mood in a Vulnerable Pregnant Population.Hantsoo, L., Criniti, S., Khan, A., et al.[2019]
Research on mobile apps for women with perinatal mood disorders shows a significant disconnect between academic studies and commercially available apps, with most academic interventions lacking presence in app stores and vice versa.
The review highlights the need for improved collaboration between academia and industry to enhance the quality and effectiveness of mHealth interventions for perinatal mental health, along with proposed practice guidelines for better implementation.
A systematic review of mHealth application interventions for peripartum mood disorders: trends and evidence in academia and industry.Feldman, N., Back, D., Boland, R., et al.[2021]
Digital health technologies can significantly enhance the management and screening of peripartum depression (PPD), which affects 10-15% of women in the U.S. annually, by utilizing a tailored framework called Digilego.
The development of specific digital features, such as 'My Diary' and 'Mom Talk', aims to improve patient engagement and address the unique needs of women experiencing PPD, with initial evaluations suggesting these features may provide technological advantages over existing solutions.
Digilego for Peripartum Depression: A Novel Patient-Facing Digital Health Instantiation.Zingg, A., Rogith, D., Refuerzo, JS., et al.[2021]

References

A Mobile Application for Monitoring and Management of Depressed Mood in a Vulnerable Pregnant Population. [2019]
A systematic review of mHealth application interventions for peripartum mood disorders: trends and evidence in academia and industry. [2021]
Digilego for Peripartum Depression: A Novel Patient-Facing Digital Health Instantiation. [2021]
Using a mobile phone application in youth mental health - an evaluation study. [2019]
Investigating perspectives on e-health interventions to enhance maternal mental well-being: Results of a stakeholder interview. [2023]
The Development of the Postpartum Depression Self-Management Mobile Application "Happy Mother". [2023]
Mobile applications as a strategy to support parents in the care of newborns: a scoping review. [2023]
Designing a Mobile Health Solution to Facilitate the Transition from NICU to Home: A Qualitative Study. [2023]
Efficacy of a mobile technology-based intervention for increasing parents' safety knowledge and actions: a randomized controlled trial. [2021]
Effectiveness of mobile application-based perinatal interventions in improving parenting outcomes: A systematic review. [2022]
Use of mobile apps and technologies in child and adolescent mental health: a systematic review. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
The effect of the Ebe Evimde application on the self-efficacy and anxiety levels of mothers: Randomized controlled trial. [2023]
Effectiveness of the 'Home-but not Alone' mobile health application educational programme on parental outcomes: a randomized controlled trial, study protocol. [2019]